TippingPoint Biosciences
Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
About
TippingPoint Biosciences is a biotechnology company focused on discovering and developing innovative antibody-based therapeutics for cancer. Their approach leverages advanced platform technologies to identify and engineer antibodies with enhanced efficacy and safety profiles. The company aims to address unmet needs in various oncology indications. Teams look it up for Biotech, Drug Discovery, Antibody Therapeutics.
Frequently asked
What does TippingPoint Biosciences do?
TippingPoint Biosciences is a Biotech company that offers Services. Teams look it up for Drug Discovery, Antibody Therapeutics, Oncology. It is based in Cambridge, Massachusetts, USA and was founded in 2021. Public records show about 7 people and $15M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has TippingPoint Biosciences raised?
TippingPoint Biosciences has raised a total of $15M in funding. The most recent round on record is Seed.
Where is TippingPoint Biosciences headquartered?
TippingPoint Biosciences is headquartered in Cambridge, Massachusetts, USA.
When was TippingPoint Biosciences founded?
TippingPoint Biosciences was founded in 2021.
What industry does TippingPoint Biosciences operate in?
TippingPoint Biosciences operates in Biotech, Drug Discovery, Antibody Therapeutics, Oncology, Genomics.
How many employees does TippingPoint Biosciences have?
TippingPoint Biosciences has approximately 7 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.